Advanced Therapeutic Antibody Discovery with Multiplexed Screening
White Paper Nov 25, 2018
Antibody-based therapeutics are the fastest growing and most successful therapeutic modality for treating numerous diseases including cancer, autoimmune disorders and infectious disease.
Multiplexed high throughput screening has become an essential component in the discovery of therapeutic antibodies.
Download this whitepaper to learn:
• How to perform multiplexed screens for antibody binding to either cell surface or to circulating target antigens.
• How the Intellicyt® iQue Screener PLUS platform can be used to carry out high content assays to evaluate the effects of lead candidates in multiplexed cell based and secreted protein assays.
Related White Papers
Download this guide for insights into the diversity of cells and signaling pathways in the immune response.
READ MOREThis study from Malvern Panalytical looks at optimal conditions for extruding liposomes as well as their stability under different conditions, highlighting the limit of detection for fluorescently labeled liposomes.
READ MOREThis document describes how Malvern Panalytical systems support system owners, meeting the requirements of the 21 CFR Part 11 regulations issued by the United States’ FDA.
READ MORELike what you just read? You can find similar content on the communities below.
Analysis & Separations Cancer Research Cell Science Genomics Research Proteomics & Metabolomics Immunology & MicrobiologyTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE
